Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model

Neuroscience

Volumn 294, Issue , 2015, Pages 38-50

  Mika, J ^a   Jurga, A M ^a   Starnowska, J ^a   Wasylewski, M ^a   Rojewska, E ^a   Makuch, W ^a   Kwiatkowski, K ^a   Malek, N ^a   Przewlocka, B ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Antidepressants; Interleukin 1 ; Interleukin 6; Ondansetron; Pain; Yohimbine

Indexed keywords

AMITRIPTYLINE; DOXEPIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; ONDANSETRON; YOHIMBINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ALBINO SWISS CD 1 MOUSE; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD PLATE TEST; CONTROLLED STUDY; CYTOKINE ACTIVATION; DISEASE ASSOCIATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HYPERALGESIA; LATENT PERIOD; MALE; MECHANICAL ALLODYNIA; MEDICAL DECISION MAKING; MOLECULAR BIOLOGY; MORNING DOSAGE; MOTOR PERFORMANCE; MOUSE; MOUSE STRAIN; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAROD TEST; SYMPTOM; THERMAL HYPERALGESIA; TREATMENT DURATION; UPREGULATION; VON FREY TEST; WESTERN BLOTTING; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DRUG EFFECTS; INJURIES; METABOLISM; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; PROCEDURES; SCIATIC NERVE;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOXEPIN; HYPERALGESIA; MALE; MICE; NEURALGIA; PAIN MEASUREMENT; PAIN THRESHOLD; SCIATIC NERVE;

EID: 84925431175     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.03.003     Document Type: Article

References (87)

1. Abbadie C., Bhangoo S., De Koninck Y., Malcangio M., Melik-Parsadaniantz S., White F.A. Chemokines and pain mechanisms. Brain Res Rev 2009, 60:125-134.
2. Adler J.E., Nico L., VandeVord P., Skoff A.M. Modulation of neuropathic pain by a glial-derived factor. Pain Med 2009, 10:1229-1236.
3. Alhaider A.A., Wilcox G.L. Differential roles of 5-hydroxytryptamine1A and 5-hydroxytryptamine1B receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Ther 1993, 265:378-385.
4. Ardid D., Jourdan D., Mestre C., Villanueva L., Le Bars D., Eschalier A. Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat. Brain Res 1995, 695:253-256.
5. Arthur J.M., Casañas S.J., Raymond J.R. Partial agonist properties of rauwolscine and yohimbine for the inhibition of adenylyl cyclase by recombinant human 5-HT1A receptors. Biochem Pharmacol 1993, 45:2337-2341.
6. Austin P.J., Moalem-Taylor G. The neuro-immune balance in neuropathic pain: involvement of inflammatory immune cells, immune-like glial cells and cytokines. J Neuroimmunol 2010, 229:26-50.
7. Benbouzid M., Choucair-Jaafar N., Yalcin I., Waltisperger E., Muller A., Freund-Mercier M.J., Barrot M. Chronic, but not acute, tricyclic antidepressant treatment alleviates neuropathic allodynia after sciatic nerve cuffing in mice. Eur J Pain 2008, 12:1008-1017.
8. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
9. Berrocoso E., Mico J.A., Vitton O., Ladure P., Newman-Tancredi A., Depoortère R., Bardin L. Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain. Eur J Pharmacol 2011, 655:46-51.
10. Cheng K.I., Wang H.C., Chang L.L., Wang F.Y., Lai C.S., Chou C.W., Tsai H.P., Kwan A.L. Pretreatment with intrathecal amitriptyline potentiates anti-hyperalgesic effects of post-injury intra-peritoneal amitriptyline following spinal nerve ligation. BMC Neurol 2012, 12:44.
11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
12. Colburn R.W., Rickman A.J., Deleo J.A. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 1999, 157:289-304.
13. Cunha J.M., Cunha F.Q., Poole S., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000, 130:1418-1424.
14. DeLeo J.A., Tanga F.Y., Tawfik V.L. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Neuroscientist 2004, 10:40-52.
15. Dobrogowski J., Przeklasa-Muszyńska A., Woroń J., Wordliczek J. Zasady kojarzenia leków w terapii bólu. Medycyna Paliatywna w Praktyce 2007, 1:6-15.
16. Dominguez E., Rivat C., Pommier B., Mauborgne A., Pohl M. JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat. J Neurochem 2008, 107:50-60.
17. Dworkin R.H., Turk D.C., Peirce-Sandner S., Baron R., Bellamy N., Burke L.B., Chappell A., Chartier K., Cleeland C.S., Costello A., Cowan P., Dimitrova R., Ellenberg S., Farrar J.T., French J.A., Gilron I., Hertz S., Jadad A.R., Jay G.W., Kalliomäki J., Katz N.P., Kerns R.D., Manning D.C., McDermott M.P., McGrath P.J., Narayana A., Porter L., Quessy S., Rappaport B.A., Rauschkolb C., Reeve B.B., Rhodes T., Sampaio C., Simpson D.M., Stauffer J.W., Stucki G., Tobias J., White R.E., Witter J. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010, 149:177-193.
18. Eisenach J.C., Gebhart G.F. Intrathecal amitriptyline acts as an N-methyl-d-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995, 83:1046-1054.
19. Farghaly H.S., Abdel-Zaher A.O., Mostafa M.G., Kotb H.I. Comparative evaluation of the effect of tricyclic antidepressants on inducible nitric oxide synthase expression in neuropathic pain model. Nitric oxide 2012, 27:88-94.
20. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005, 118:289-305.
21. Fuller R.W., Wong D.T. Inhibition of serotonin reuptake. Fed Proc 1977, 36:2154-2158.
22. Gao Y., Ji R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010, 126:56-68.
23. Gao Y.J., Cheng J.K., Zeng Q., Xu Z.Z., Decosterd I., Xu X., Ji R.R. Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model. Exp Neurol 2009, 219:146-155.
24. Giulian D., Baker T.J., Shih L.C., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986, 164:594-604.
25. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005, 116:109-118.
26. Green G.M., Scarth J., Dickenson A. An excitatory role for 5-HT in spinal inflammatory nociceptive transmission; state-dependent actions via dorsal horn 5-HT(3) receptors in the anaesthetized rat. Pain 2000, 89:81-88.
27. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15:307-339.
28. Guo W., Miyoshi K., Dubner R., Gu M., Li M., Liu J., Yang J., Zou S., Ren K., Noguchi K., Wei F. Spinal 5-HT3 receptors mediate descending facilitation and contribute to behavioral hypersensitivity via a reciprocal neuron-glial signaling cascade. Mol Pain 2014, 10:35.
29. Hajhashemi V., Banafshe H.R., Minaiyan M., Mesdaghinia A., Abed A. Antinociceptive effects of venlafaxine in a rat model of peripheral neuropathy: role of alpha2-adrenergic receptors. Eur J Pharmacol 2014, 10.1016/j.ejphar.2014.04.046.
30. Hayashida K., Kimura M., Yoshizumi M., Hobo S., Obata H., Eisenach J.C. Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury: role of γ-aminobutyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia. Anesthesiology 2012, 117:389-398.
31. Hopkins S.J., Rothwell N.J. Cytokines and the nervous system I: expression and recognition. Trends Neurosci 1995, 18:83-88.
32. Available from: http://services.medicines.org.uk/assethosting/assets/printable/a/m/amitriptyline%20hydrochloride/printable.1385_87_124.pdf.
33. Available from: http://www.drugs.com/.
34. Huang Y.N., Tsai R.Y., Lin S.L., Chien C.C., Cherng C.H., Wu C.T., Yeh C.C., Wong C.S. Amitriptyline attenuates astrocyte activation and morphine tolerance in rats: role of the PSD-95/NR1/nNOS/PKCγ signaling pathway. Behav Brain Res 2012, 229:401-411.
35. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67:313-316.
36. Jagla G., Mika J., Makuch W., Obara I., Wordliczek J., Przewlocka B. Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain. Pharm Rep 2014, 66:459-465.
37. Jesse C.R., Wilhelm E.A., Nogueira C.W. Depression-like behavior and mechanical allodynia are reduced by bis selenide treatment in mice with chronic constriction injury: a comparison with fluoxetine, amitriptyline, and bupropion. Psychopharmacology (Berl) 2010, 212:513-522.
38. Kalso E., Edwards J.E., Moore R.A., McQuay H.J. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004, 112:372-380.
39. Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28:5189-5194.
40. Kim Y.S., Chu Y., Han L., Li M., Li Z., Lavinka P.C., Sun S., Tang Z., Park K., Caterina M.J., Ren K., Dubner R., Wei F., Dong X. Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain. Neuron 2014, 81:873-887.
41. Kjørsvik A., Tjølsen A., Hole K. Activation of spinal serotonin(2A/2C) receptors augments nociceptive responses in the rat. Brain Res 2001, 910:179-181.
42. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19:312-318.
43. Lee K.M., Jeon S.M., Cho H.J. Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur J Pain 2010, 14:682.
44. Mannisto P.T., Saarnivaara L. Effects of lithium and rubidium on antinociception and behaviour in mice. II. Studies on three tricyclic antidepressants and pimozide. Arch Int Pharmacodyn Ther 1976, 222:293-299.
45. Mao Q.T., Yang T.D. Amitriptyline upregulates EAAT1 and EAAT2 in neuropathic pain rats. Brain Res Bull 2010, 81:424-427.
46. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 1987, 37. 589-396.
47. McCleane G. Tropical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000, 49:574-579.
48. McCleane G. Antidepressants as analgesics. CNS Drugs 2008, 22:139-156.
49. McDermott A.M., Toelle T.R., Rowbotham D.J., Schaefer C.P., Dukes E.M. The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain 2006, 10:127-135.
50. Micó J.A., Ardid D., Berrocoso E., Eschalier A. Antidepressants and pain. Trends Pharmacol Sci 2006, 27:348-354.
51. Mika J., Korostynski M., Kaminska D., Wawrzczak-Bargiela A., Osikowicz M., Makuch W., Przewlocki R., Przewlocka B. Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model. Pain 2008, 138:587-597.
52. Mika J., Osikowicz M., Makuch W., Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 2007, 560:142-149.
53. Mika J., Osikowicz M., Rojewska E., Korostynski M., Wawrzczak-Bargiela A., Przewlocki R., Przewlocka B. Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain. Eur J Pharmacol 2009, 623:65-72.
54. Mika J., Zychowska M., Popiolek-Barczyk K., Rojewska E., Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol 2013, 716:106-119.
55. Millan M.J. Descending control of pain. Prog Neurobiol 2002, 66:355-474.
56. Millan M.J., Newman-Tancredi A., Audinot V., Cussac D., Lejeune F., Nicolas J.P., Cogé F., Galizzi J.P., Boutin J.A., Rivet J.M., Dekeyne A., Gobert A. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 2000, 35:79-95.
57. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36.
58. Murakami F., Kobayashi Y., Uratani T., Tamada A. Individual corticorubral neurons project bilaterally during postnatal development and following early contralateral cortical lesions. Exp Brain Res 1993, 96:181-193.
59. Osikowicz M., Mika J., Makuch W., Przewlocka B. Glutamate receptor ligands attenuate allodynia and hyperalgesia and potentiate morphine effects in a mouse model of neuropathic pain. Pain 2008, 139:117-126.
60. Ozdoğan U.K., Lähdesmäki J., Mansikka H., Scheinin M. Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice. Eur J Pharmacol 2004, 485:193-196.
61. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992, 29:243-246.
62. Rothwell N.J. Neuroimmune interactions: the role of cytokines. Br J Pharmacol 1997, 121:841-847.
63. Saarto T., Wiffen P.J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2007, 4:CD005454.
64. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol 1995, 115:1265-1275.
65. 2-adrenoceptors and spinal astrocytes. J Pharmacol Sci 2014, 124:244-257.
66. Sansone R.A., Sansone L.A. Pain, pain, go away: antidepressants and pain management. Psychiatry (Edgemont) 2008, 5:16-29.
67. Schäfers M., Lee D.H., Brors D., Yaksh T.L., Sorkin L.S. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-α after spinal nerve ligation. J Neurosci 2003, 23:3028-3038.
68. Shavit Y., Wolf G., Goshen I., Livshits D., Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 2005, 115:50-59.
69. Sommer C (2001) Cytokines and neuropathic pain. In: Neuropathic pain: pathophysiology and treatment, Vol. 21 (Hansson P, Fields H, Hill R, Marchettini P, eds), pp 37-62.
70. Sommer C. Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 2004, 30:117-125. Review.
71. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci Lett 1999, 270:25-28.
72. Sommer C., Schäfers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 1998, 784:154-162.
73. Suter M.R., Kirschmann G., Laedermann C.J., Abriel H., Decosterd I. Rufinamide attenuates mechanical allodynia in a model of neuropathic pain in the mouse and stabilizes voltage-gated sodium channel inactivated state. Anesthesiology 2013, 118:160-172.
74. Suzuki R., Rahman W., Hunt S.P., Dickenson A.H. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res 2004, 1019:68-76.
75. Sweitzer S., Martin D., DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 2001, 103:529-539.
76. Touzani O., Boutin H., Chuquet J., Rothwell N. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol 1999, 100:203-215.
77. Trang T., Beggs S., Wan X., Salter M.W. P2X4-receptor-mediated synthesis and release of brain-derived neurotrophic factor in microglia is dependent on calcium and p38-mitogen-activated protein kinase activation. J Neurosci 2009, 29:3518-3528.
78. Tuveson B., Leffler A.S., Hansson P. Ondansetron, a 5-HT3-antagonist, does not alter dynamic mechanical allodynia or spontaneous ongoing pain in peripheral neuropathy. Clin J Pain 2011, 27:323-329.
79. Verdu B., Decosterd I., Buclin T., Stiefel F., Berney A. Antidepressants for the treatment of chronic pain. Drugs 2008, 68:2611-2632.
80. Watkins C.C., Sawa A., Pomper M.G. Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application. Transl Psychiatry 2014, 4:e350.
81. White F.A., Wilson N.M. Chemokines as pain mediators and modulators. Curr Opin Anaesthesiol 2008, 21:580-585.
82. Wrzosek A., Obara I., Wordliczek J., Przewlocka B. Efficacy of tramadol in combination with doxepin or venlafaxine in inhibition of nociceptive process in the rat model of neuropathic pain: an isobolographic analysis. J Physiol Pharmacol 2009, 60:71-78.
83. Yamauchi K., Osuka K., Takayasu M., Usuda N., Nakazawa A., Nakahara N., Yoshida M., Aoshima C., Hara M., Yoshida J. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem 2006, 96:1060-1070.
84. Yasuda T., Miki S., Yoshinaga N., Senba E. Effects of amitriptyline and gabapentin on bilateral hyperalgesia observed in an animal model of unilateral axotomy. Pain 2005, 115:161-170.
85. Zbârcea C.E., Negreş S., Nicoleta Cristea A., Chiriţă C. The effect of dextromethorphan, gabapentin, amitriptyline and tramadol on a mouse model of vincristine - induced peripheral neuropathy. Farmacia 2011, 59:809-819.
86. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110.
87. Zychowska M., Rojewska E., Makuch W., Przewlocka B., Mika J. The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain. Eur J Pharmacol 2014, 749C:115-123.